Clinical Trial Update: Impact of the Administration of Fludrocortisone in Very Premature Infants [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fludrocortisone in very premature infants with partial mineralocorticoid deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Mineralocorticoid Deficiency in Premature Infants

Drugs mentioned

• Fludrocortisone (Fludrocortisone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Partial Mineralocorticoid Deficiency | Phase 2 | Status: COMPLETED